Larvol Delta - Evaluating-the-Safety-Tolerability-Pharmacokinetics-and-Receptor-Occupancy-of-BMS984923

ALX-001 - Allyx Therap

http://clinicaltrials.gov/ct2/show/NCT04805983

Jun 24, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev